Docking Study to Predict the Efficacy of Phosphatidylinositol 3-Kinase Α Inhibitors

ARO-THE SCIENTIFIC JOURNAL OF KOYA UNIVERSITY
doi 10.14500/aro.10565
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Koya University

Related search

Treating Cancer With Phosphatidylinositol-3-Kinase Inhibitors: Increasing Efficacy and Overcoming Resistance

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2019English

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Phosphatidylinositol 3-Kinase Inhibitors Are a Triple Threat to Ovarian Cancer

Clinical Cancer Research
Cancer ResearchOncology
2005English

Clinical Development of Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin Lymphoma

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2013English

Phosphatidylinositol-3-Kinase Pathway

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Regulation of the P85/P110α Phosphatidylinositol 3′-Kinase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Association of P21ras With Phosphatidylinositol 3-Kinase.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Levels of Target Activation Predict Antifibrotic Responses to Tyrosine Kinase Inhibitors

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2013English

Phosphatidylinositol 3-Kinase Signaling Determines Kidney Size

Journal of Clinical Investigation
Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy